Association of C-reactive protein (CRP) gene allelic variants with serum CRP levels and hypertension in Turkish adults

Atherosclerosis

Volumn 206, Issue 2, 2009, Pages 474-479

  Komurcu Bayrak, E ^a,b   Erginel Unaltuna, N ^a   Onat, A ^a   Ozsait, B ^a,b   Eklund, C ^c   Hurme, M ^c   Mononen, N ^b   Laaksonen, R ^b   Hergenc, G ^d   Lehtimaki T ^b  

^a ISTANBUL UNIVERSITY   (Turkey)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d YILDIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

C reactive protein; Haplotype; Hypertension; Polymorphism; Turkish population

Indexed keywords

ADENINE; C REACTIVE PROTEIN; CYTOSINE; GUANINE; THYMINE;

ABDOMINAL OBESITY; ADULT; ALLELE; ARTICLE; ASIAN; CARDIOVASCULAR RISK; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SINGLE NUCLEOTIDE POLYMORPHISM; TURKEY (REPUBLIC);

ADULT; ALLELES; C-REACTIVE PROTEIN; FEMALE; HAPLOTYPES; HUMANS; HYPERTENSION; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY;

EID: 70349411615     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.03.030     Document Type: Article

References (28)

1. Torzewski J., Torzewski M., Bowyer D.E., et al. C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18 (1998) 1386-1392
2. Jylhä M., Paavilainen P., Lehtimäki T., et al. Interleukin-1 receptor antagonist, interleukin-6, and C-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci 62 (2007) 1016-1021
3. Järvisalo M.J., Harmoinen A., Hakanen M., et al. Elevated serum C-reactive protein levels and early arterial changes in healthy children. Arterioscler Thromb Vasc Biol 22 (2002) 1323-1328
4. Nissen S.E., Tuzcu E.M., Schoenhagen P., et al. Reversal of atherosclerosis with aggressive lipid lowering (REVERSAL) investigators. Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. N Engl J Med 352 (2005) 29-38
5. Sattar N., Gaw A., Scherbakova O., et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 108 (2003) 414-419
6. Rutter M.K., Meigs J.B., Sullivan L.M., D'Agostino Sr. R.B., and Wilson P.W. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 110 (2004) 380-385
7. Miller M., Zhan M., and Havas S. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey. Arch Int Med 165 (2005) 2063-2068
8. Davey Smith G., Lawlor D.A., Harbord R., et al. Association of C-reactive protein with blood pressure and hypertension: life course confounding and mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 25 (2005) 1051-1056
9. Onat A., Can G., and Hergenc G. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk. Metabolism 57 (2008) 207-214
10. Onat A., Sansoy V., Yildirim B., Keles I., Uysal O., and Hergenc G. C-reactive protein and coronary heart disease in western Turkey. Am J Cardiol 88 (2001) 601-607
11. MacGregor A.J., Gallimore J.R., Spector T.D., and Pepys M.B. Genetic effects on baseline values of C-reactive protein and serum amyloid a protein: a comparison of monozygotic and dizygotic twins. Clin Chem 50 (2004) 130-134
12. Pankow J.S., Folsom A.R., Cushman M., et al. Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study. Atherosclerosis 154 (2001) 681-689
13. Kathiresan S., Larson M.G., Vasan R.S., et al. Contribution of clinical correlates and C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level. Circulation 113 (2006) 1415-1423
14. Carlson C.S., Aldred S.F., Lee P.K., et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet 77 (2005) 64-77
15. Crawford D.C., Sanders C.L., Qin X., et al. Genetic variation is associated with C-reactive protein levels in the Third National Health and Nutrition Examination Survey. Circulation 114 (2006) 2458-2465
16. Miller D.T., Zee R.Y., Suk Danik J., et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet 69 (2005) 623-638
17. Eklund C., Kivimäki M., Islam M.S., et al. C-reactive protein genetics is associated with carotid artery compliance in men in The Cardiovascular Risk in Young Finns Study. Atherosclerosis 196 (2008) 841-848
18. Lange L.A., Carlson C.S., Hindorff L.A., et al. Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events. JAMA 296 (2006) 2703-2711
19. Hindorff L.A., Rice K.M., Lange L.A., et al. Common variants in the CRP gene in relation to longevity and cause-specific mortality in older adults: the Cardiovascular Health Study. Atherosclerosis 197 (2008) 922-930
20. Hurme M., Kivimäki M., Pertovaara M., et al. CRP gene is involved in the regulation of human longevity: a follow-up study in Finnish nonagenarians. Mech Ageing Dev 128 (2007) 574-576
21. Onat A. Risk factors and cardiovascular disease in Turkey. Atherosclerosis 156 (2001) 1-10
22. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 (2001) 2486-2497
23. Grundy S.M., Brewer Jr. H.B., Cleeman J.I., Smith Jr. S.C., and Lenfant C. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109 (2004) 433-438
24. Onat A., Uyarel H., Hergenc G., Karabulut A., Albayrak S., and Can G. Determinants and definition of abdominal obesity as related to risk of diabetes, metabolic syndrome and coronary disease in Turkish men: a prospective cohort study. Atherosclerosis 191 (2007) 182-190
25. Onat A., Hergenç G., and Can G. Prospective validation in identical Turkish cohort of two metabolic syndrome definitions for predicting cardiometabolic risk and selection of most appropriate definition. Anadolu Kardiyol Derg 7 (2007) 29-34
26. Eklund C., Nenonen A., Kukkonen-Harjula K., et al. Association of the IL6 174(G/C) polymorphism with C-reactive protein concentration after weight loss in obese men. Eur Cytokine Netw 17 (2006) 131-135
27. Wessel J., Moratorio G., Rao F., et al. C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci. J Hypertens 25 (2007) 329-343
28. Timpson N.J., Lawlor D.A., Harbord R.M., et al. C-reactive protein and its role in metabolic syndrome: mendelian randomisation study. Lancet 366 (2005) 1954-1959